Hello and Welcome to Patientsville.com, Your Source for all VASTEN information. We are dedicated to provide You with VASTEN safety information. Learn about VASTEN serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
VASTEN Safety Reports
Total VASTEN reports: 31.VASTEN FDA safety alerts: No.
Reported deaths: 3 Reported hospitalizations: 17.
Take VASTEN Side Effects Survey or Share Your VASTEN Story. Read More Here.
Health Professional from FRANCE reported VASTEN problem on Dec 21, 2006. Female patient, 78 years of age, was diagnosed with back pain and was treated with VASTEN. After drug was administered, patient experienced the following problems/side effects: agitation, back pain, confusional state, fall, hyponatraemia, intervertebral disc compression, vomiting. VASTEN dosage: unknown. During the same period patient was treated with TRAMADOL, ALDACTONE, OMEPRAZOLE, PREVISCAN, SOTALOL, TRIVASTAL LP, TENORMIN, HEXAQUINE. Patient was hospitalized. Patient recovered.
VASTEN problem was reported by a Health Professional from FRANCE on Jan 19, 2007. Female patient, 74 years of age, was diagnosed with hypercholesterolaemia and was treated with VASTEN. After drug was administered, patient experienced the following problems/side effects: pancytopenia. VASTEN dosage: unknown. During the same period patient was treated with ALLOPURINOL. Patient was hospitalized. Patient recovered.
Health Professional from FRANCE reported VASTEN problem on Jan 25, 2007. Male patient, 49 years of age, was diagnosed with hypercholesterolaemia, psoriasis, embolism, myocardial infarction and was treated with VASTEN. After drug was administered, patient experienced the following problems/side effects: pulmonary embolism. VASTEN dosage: unknown. During the same period patient was treated with RAPAMUNE, ASPIRIN, AMLOR. Patient recovered.
VASTEN problem was reported by a Health Professional from FRANCE on Feb 21, 2007. Male patient, 49 years of age, was diagnosed with hypercholesterolaemia, psoriasis, embolism, myocardial infarction and was treated with VASTEN. After drug was administered, patient experienced the following problems/side effects: pulmonary embolism. VASTEN dosage: unknown. During the same period patient was treated with RAPTIVA, ASPIRIN, AMLODIPINE. Patient recovered.
Health Professional from FRANCE reported VASTEN problem on Feb 21, 2007. Male patient, 67 years of age, was treated with VASTEN. After drug was administered, patient experienced the following problems/side effects: hypoglycaemia. VASTEN dosage: unknown. During the same period patient was treated with NOVONORM, ACARBOSE, NEXIUM, PERINDOPRIL ERBUMINE, PLAVIX, LASIX. Patient was hospitalized. Patient recovered.
VASTEN problem was reported by a Pharmacist from FRANCE on Mar 28, 2007. Female patient, 82 years of age, was diagnosed with hypercholesterolaemia, hypothyroidism, hypertension, cardiac disorder, gastrointestinal disorder, osteoarthritis, sleep disorder and was treated with VASTEN. After drug was administered, patient experienced the following problems/side effects: corneal disorder, corneal epithelium defect, dry eye, visual acuity reduced, visual disturbance. VASTEN dosage: INITIAL WAS 10MG FROM 1991-13-OCT-2004. During the same period patient was treated with LEVOTHYROXINE, IRBESARTAN, VASTAREL, ISOPTIN, DEBRIDAT, CHONDROITIN SULPHATE, TEMESTA. Patient recovered.
Consumer or non-health professional from FRANCE reported VASTEN problem on Apr 11, 2007. Female patient, 64 years of age, was treated with VASTEN. VASTEN dosage: unknown. Patient died.
VASTEN problem was reported by a Physician from FRANCE on June 26, 2006. Female patient, 63 years of age, was treated with VASTEN. After drug was administered, patient experienced the following problems/side effects: conjunctival haemorrhage. VASTEN dosage: unknown. Patient recovered.
Health Professional from FRANCE reported VASTEN problem on Apr 07, 2006. Male patient, 80 years of age, was diagnosed with hypercholesterolaemia and was treated with VASTEN. After drug was administered, patient experienced the following problems/side effects: anorexia, blood creatine phosphokinase increased, cytolytic hepatitis, hepatitis cholestatic, thrombocytopenia. VASTEN dosage: unknown. During the same period patient was treated with PANTOPRAZOLE, BUFLOMEDIL, NITRODERM, PREVISCAN, LOPRESSOR. Patient was hospitalized. Patient recovered.
VASTEN problem was reported by a Health Professional from FRANCE on July 17, 2006. Female patient, 16 years of age, was diagnosed with lipids abnormal and was treated with VASTEN. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus. VASTEN dosage: unknown. During the same period patient was treated with PROGRAF, CELLCEPT, SOLUPRED, TARDYFERON, NEORAL. Patient was hospitalized. Patient recovered.
Health Professional from FRANCE reported VASTEN problem on July 17, 2006. Female patient, 25 years of age, was diagnosed with prophylaxis and was treated with VASTEN. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus. VASTEN dosage: unknown. During the same period patient was treated with OMEPRAZOLE, PROGRAF, ASPIRIN, CELLCEPT. Patient was hospitalized. Patient recovered.
VASTEN problem was reported by a Health Professional from FRANCE on July 17, 2006. Female patient, 82 years of age, was diagnosed with hypertension, depression, osteoporosis and was treated with VASTEN. After drug was administered, patient experienced the following problems/side effects: antinuclear antibody positive, deep vein thrombosis, infection, pleural effusion, pleurisy, pulmonary embolism. VASTEN dosage: unknown. During the same period patient was treated with XALACOM, CATAPRES, COZAAR, PRAXILENE, ISOPTIN, SEROPRAM, EVISTA, ASPIRIN. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from FRANCE reported VASTEN problem on July 20, 2006. Female patient, 73 years of age, was diagnosed with blood cholesterol increased and was treated with VASTEN. After drug was administered, patient experienced the following problems/side effects: arthralgia, chest pain, fatigue, palpitations. VASTEN dosage: unknown. Patient recovered.
VASTEN problem was reported by a Health Professional from FRANCE on July 25, 2006. Female patient, 78 years of age, was diagnosed with hypercholesterolaemia, atrial fibrillation and was treated with VASTEN. After drug was administered, patient experienced the following problems/side effects: subdural haematoma. VASTEN dosage: unknown. During the same period patient was treated with PREVISCAN. Patient was hospitalized. Patient died on 06/30/2006.
Health Professional from FRANCE reported VASTEN problem on July 27, 2006. Female patient, 60 years of age, was diagnosed with hypercholesterolaemia, sciatica, essential hypertension, bronchitis chronic, menopause and was treated with VASTEN. After drug was administered, patient experienced the following problems/side effects: colitis. VASTEN dosage: unknown. During the same period patient was treated with FELDENE, ISOPTIN, SYMBICORT, UTROGESTAN, ESTREVA, NEXIUM, DUPHALAC, PROZAC. Patient was hospitalized. Patient recovered.
VASTEN problem was reported by a Health Professional from FRANCE on Mar 10, 2006. Male patient, 70 years of age, was treated with VASTEN. After drug was administered, patient experienced the following problems/side effects: anorexia, asthenia, eosinophilic fasciitis, oedema peripheral, pain in extremity, weight decreased. VASTEN dosage: unknown. Patient was hospitalized. Patient recovered.
Health Professional from FRANCE reported VASTEN problem on Aug 07, 2006. Male patient, 83 years of age, was treated with VASTEN. After drug was administered, patient experienced the following problems/side effects: acute coronary syndrome, renal failure chronic. VASTEN dosage: unknown. During the same period patient was treated with PREVISCAN, CORVASAL, COVERSYL, LASILIX, AMARYL, GLUCOPHAGE, DIASTABOL, CARDENSIEL. Patient was hospitalized. Patient recovered.
VASTEN problem was reported by a Pharmacist from FRANCE on Apr 21, 2006. Male patient, 55 years of age, was diagnosed with hypercholesterolaemia, diabetes mellitus and was treated with VASTEN. After drug was administered, patient experienced the following problems/side effects: hepatocellular damage, hypoglycaemia. VASTEN dosage: unknown. During the same period patient was treated with METFORMIN HYDROCHLORIDE, PERINDOPRIL ERBUMINE, VERAPAMIL, CLOPIDOGREL BISULPHATE. Patient recovered.
Health Professional from FRANCE reported VASTEN problem on Sept 04, 2006. Male patient, 71 years of age, was diagnosed with hypercholesterolaemia and was treated with VASTEN. After drug was administered, patient experienced the following problems/side effects: myalgia, tendonitis. VASTEN dosage: unknown. During the same period patient was treated with PRAVASTATIN, ASPIRIN, SECTRAL, TRANDOLAPRIL. Patient recovered.
VASTEN problem was reported by a Consumer or non-health professional from FRANCE on Sept 21, 2006. Male patient, 53 years of age, was diagnosed with hypercholesterolaemia, gastrooesophageal reflux disease and was treated with VASTEN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, asthenia, chromaturia, hepatitis acute, jaundice, transaminases increased. VASTEN dosage: unknown. During the same period patient was treated with OMEPRAZOLE. Patient recovered.
Physician from FRANCE reported VASTEN problem on Sept 22, 2006. Male patient, 40 years of age, was diagnosed with hypercholesterolaemia, stent placement and was treated with VASTEN. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, muscular weakness, myalgia, transaminases increased. VASTEN dosage: unknown. During the same period patient was treated with PLAVIX. Patient recovered.
VASTEN problem was reported by a Physician from FRANCE on Sept 22, 2006. Male patient, 40 years of age, was diagnosed with hypercholesterolaemia, stent placement and was treated with VASTEN. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, muscular weakness, myalgia, transaminases increased. VASTEN dosage: unknown. During the same period patient was treated with PLAVIX. Patient recovered.
Health Professional from FRANCE reported VASTEN problem on Sept 04, 2006. Male patient, 71 years of age, was diagnosed with hypercholesterolaemia, coronary artery bypass, myocardial infarction and was treated with VASTEN. After drug was administered, patient experienced the following problems/side effects: insomnia, myalgia, pain in extremity, tendonitis. VASTEN dosage: unknown. During the same period patient was treated with PRAVASTATIN, ASPIRIN, SECTRAL, TRANDOLAPRIL, TANAKAN, VOLTAREN. Patient recovered.
VASTEN problem was reported by a Physician from FRANCE on Sept 22, 2006. Male patient, 49 years of age, weighting 174.2 lb, was diagnosed with hypercholesterolaemia, angina pectoris and was treated with VASTEN. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, fatigue, muscular weakness, myalgia, transaminases increased. VASTEN dosage: unknown. During the same period patient was treated with CLOPIDOGREL BISULPHATE, PRAVASTATIN, ASPIRIN, TENORMIN. Patient recovered.
Physician from FRANCE reported VASTEN problem on Sept 22, 2006. Male patient, weighting 173.5 lb, was diagnosed with hypercholesterolaemia, angina pectoris, stent placement and was treated with VASTEN. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, muscular weakness, myalgia, transaminases increased. VASTEN dosage: unknown. During the same period patient was treated with TENORMIN, ASPIRIN, PLAVIX. Patient recovered.
VASTEN problem was reported by a Health Professional from FRANCE on Oct 30, 2006. Male patient, 73 years of age, was diagnosed with myocardial infarction, bronchial carcinoma, deep vein thrombosis and was treated with VASTEN. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased. VASTEN dosage: unknown. During the same period patient was treated with CORVASAL, TRIATEC, TILDIEM, ALIMTA, PREVISCAN. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from FRANCE reported VASTEN problem on Nov 06, 2006. Female patient, 91 years of age, was treated with VASTEN. After drug was administered, patient experienced the following problems/side effects: rectal haemorrhage. VASTEN dosage: unknown. During the same period patient was treated with ALLOPURINOL, CORDARONE, PREVISCAN, IMODIUM, TIORFAN, LASIX, ACETAMINOPHEN, NEORECORMON. Patient was hospitalized. Patient recovered.
VASTEN problem was reported by a Health Professional from FRANCE on Nov 06, 2006. Female patient, 91 years of age, was treated with VASTEN. After drug was administered, patient experienced the following problems/side effects: rectal haemorrhage. VASTEN dosage: unknown. During the same period patient was treated with ALLOPURINOL, CORDARONE, PREVISCAN, IMODIUM, TIORFAN, LASIX, ACETAMINOPHEN, NEORECORMON. Patient was hospitalized. Patient recovered.
Health Professional from FRANCE reported VASTEN problem on Nov 20, 2006. Male patient, 55 years of age, was treated with VASTEN. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, anaemia, cardio-respiratory arrest, febrile neutropenia, platelet count decreased. VASTEN dosage: unknown. During the same period patient was treated with RIFADIN, CLAMOXYL, NEURONTIN, AMOXICILLIN, GABAPENTIN. Patient was hospitalized. Patient died on 10/04/2006.
VASTEN problem was reported by a Health Professional from FRANCE on Aug 29, 2007. Female patient, 25 years of age, was diagnosed with prophylaxis and was treated with VASTEN. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus. VASTEN dosage: unknown. During the same period patient was treated with MOPRAL, PROGRAF, KARDEGIC, CELLCEPT. Patient was hospitalized. Patient recovered.
Health Professional from FRANCE reported VASTEN problem on Aug 29, 2007. Male patient, 66 years of age, was diagnosed with hypercholesterolaemia, ischaemic heart disease prophylaxis, myocardial infarction, atrial fibrillation and was treated with VASTEN. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, cytolytic hepatitis, fibrin increased, hepatocellular damage, myalgia. VASTEN dosage: unknown. During the same period patient was treated with CELIPROLOL, LASIX, PREVISCAN, LISINOPRIL. Patient was hospitalized. Patient recovered.